Abstract Library

#3442 Surgical management of patients with sporadic Zollinger-Ellison Syndrome: An ACHBT and GTE study

Introduction: The only curative treatment of sporadic gastrinoma is complete surgical resection, but its surgical management remain controversial.

Conference:

Presenting Author: Gaujoux S

Authors: Gaujoux S, Robin L, Sauvanet A, Walter T, Naja H,

Keywords: gastrinoma, surgery, pancreaticoduodenectomy, lymphadenectomy,

#690 Primary Lymph Node Gastrinoma or Metastatic Gastrinoma with Unidentified Primary Tumor Site?

Introduction: The existence of primary lymph node gastrinoma remains controversial.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Martin J, Tedeschi M, Jackson J, Spalding D, Goldstone A,

Keywords: gastrinoma, lymph node,

#525 Pancreatic Neuroendocrine Tumors Associated with Mesenchimal Neoplasms of the GI Tract

Introduction: Neuroendocrine pancreatic tumors (NPT) are occasionally associated with mesenchimal tumors in neurofibromatosis type 1 but rarely in sporadic cases. We report five cases of NPT associated with other rare mesenchimal neoplasms of the GI tract, observed in our Department from 2003 to 2011.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Moletta L, Milanetto A, Alaggio R, Sperti C, Pedrazzoli S,

Keywords: pancreatic neuroendocrine tumors, GIST, pancreatic resection,

#277 Metastatic Gastrinoma Co-secreting PTHrP and ACTH

Introduction: Metastatic gastrinoma is occasionally associated with tumor secretion of functioning peptides, resulting in additional syndromes.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Joharatnam J, Carroll R, Galliford T, Downie B, Zissimopoulos A,

Keywords: metastatic gastrinoma, neuroendocrine tumour, co-secretion, PTHrP, ACTH,

#21 Peptide Receptor Radioligand Therapy (PRRT) is an Effective Treatment for the Long-Term Stabilization of Malignant Gastrinomas

Introduction: Gastrinomas represent a rare group of neuroendocrine tumors usually located in the duodenum or pancreas. They secrete gastrin, which is responsible for the clinical picture of severe acid-related peptic disease and diarrhea, known as the Zollinger-Ellison syndrome (ZES). While symptomatic control may be achieved with proton-pump inhibitors (PPIs) and somatostatin analogues (SSAs) treatment, little data is known regarding the possible anti-tumor effect of the peptide receptor radioligand therapy (PRRT) in gastrinoma patients.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Grozinsky-Glasberg S, Barak D, Fraenkel M, Müeller J, Shimon I,

Keywords: PRRT, malignant gastrinoma, treatment, anti-tumor effect ,